LASER VERSUS CRYSTALLIZED PHENOL IN PILONIDAL SINUS DISEASE

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorSanliurfa Education and Research Hospital

About this trial

This single-center prospective randomized parallel-group trial compares laser ablation and crystallized phenol application in adults with primary uncomplicated sacrococcygeal pilonidal sinus disease. The primary objective is to compare postoperative day 1 pain intensity between the two treatment methods. Secondary objectives include complete epithelialization by day 30, time to complete epithelialization, postoperative day 7 pain, duration of analgesic use, time to return to daily activities and work, early local complications, and 6-month recurrence.

Eligibility criteria

Qualifiers

Age 18 years or older

Diagnosis of primary chronic sacrococcygeal pilonidal sinus disease

Uncomplicated disease

Suitability for minimally invasive treatment

Disqualifiers

Acute pilonidal abscess

History of pilonidal abscess drainage

Previous surgical or interventional treatment for pilonidal sinus disease

Recurrent pilonidal disease

Trial design

Treatments tested in this trial

  • Laser Ablation
  • Crystallized phenol application

Treatment groups

120 Participants
are divided into 2 treatment groups

Locations

This trial has no locations